Myasthenia Gravis Therapy
Study findings from Uppsala University, Department of Clinical Neurophysiology broaden understanding of myasthenia gravis therapy
Published in Women's Health Weekly, April 3rd, 2008
A new study, 'Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis,' is now available. "The aim of this prospective study was to assess whether extra discharges (EDs), sometimes following the compound muscle action potential, could be used as a neurophysiological indicator of overdose of acetylcholinesterase inhibitors (AChEIs) in patients with myasthenia gravis (MG). The characteristics and frequency of EDs were explored and the correlation of EDs with cholinergic side effects was also determined," scientists in Uppsala, Sweden report.
"Twenty-two MG patients (14 women, 8 men; 61...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Chromosomal Abnormalities
Study links dietary folate intake to genetic abnormalities in sperm - Heart Disease
Women are treated less frequently than men with statins, aspirin and beta-blockers - HIV/AIDS
Researchers develop new tool to predict who will use microbicides - Osteoporosis
Gene variants associated with increased risk of bone fractures, low bone mineral density - Post-Traumatic Stress Disorders
Variations of stress response gene appear to be predictive of risk of PTSD - University of Texas at Austin
Do attractive women want it all? - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
